Trials / Completed
CompletedNCT00908453
The Study of NPC-06 - Investigation of Safety, Efficacy and Pharmacokinetics of Fosphenytoin
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Nobelpharma · Industry
- Sex
- All
- Age
- 2 Years
- Healthy volunteers
- Not accepted
Summary
The study is to evaluate safety, efficacy and pharmacokinetics of intravenously administered fosphenytoin in patients with neurosurgery, head trauma, epilepsy or status epilepticus who are requiring a loading dose of phenytoin.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | fosphenytoin | 15mg/kg, 18mg/kg or 22.5mg/kg of loading doses of fosphenytoin |
Timeline
- Start date
- 2009-05-01
- Primary completion
- 2010-02-01
- Completion
- 2010-02-01
- First posted
- 2009-05-25
- Last updated
- 2010-05-24
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT00908453. Inclusion in this directory is not an endorsement.